Literature DB >> 8323401

Large vessel occlusive disease associated with CREST syndrome and scleroderma.

P Youssef1, H Englert, J Bertouch.   

Abstract

OBJECTIVES: To report the cases of three patients with CREST syndrome and one patient with diffuse scleroderma who had severe macrovascular disease and only minimal vascular risk factors.
METHODS: The medical histories, physical examinations, and results of clinical investigations were reviewed in four patients.
RESULTS: These four patients had severe morbidity from macrovascular disease of the arms and legs in the presence of minimal underlying vascular risk factors. These patients represent 11% of the women with scleroderma seen at our hospital since 1974. This is a greater than threefold increase above the expected proportion of symptomatic vascular disease seen in population studies. In the patients with CREST syndrome, large vessel disease was first seen more than 10 years after the onset of Raynaud's phenomenon, which was the first manifestation of the disease. A pathological specimen of the ulnar artery from one patient showed severe luminal narrowing by an acellular material with no evidence of atheroma.
CONCLUSIONS: These cases suggest an association of both the CREST syndrome and scleroderma with macrovascular disease.

Entities:  

Mesh:

Year:  1993        PMID: 8323401      PMCID: PMC1005074          DOI: 10.1136/ard.52.6.464

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Pathogenesis of systemic sclerosis: a vascular hypothesis.

Authors:  P M Campbell; E C LeRoy
Journal:  Semin Arthritis Rheum       Date:  1975-05       Impact factor: 5.532

2.  Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study.

Authors:  T Gordon; W B Kannel
Journal:  JAMA       Date:  1972-08-14       Impact factor: 56.272

Review 3.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

4.  Electron microscopic observations on skeletal muscle in diffuse scleroderma.

Authors:  R Michalowski; J Kudejko
Journal:  Br J Dermatol       Date:  1966-01       Impact factor: 9.302

5.  Carotid arteritis and cerebral infarction due to scleroderma.

Authors:  J E Lee; J M Haynes
Journal:  Neurology       Date:  1967-01       Impact factor: 9.910

6.  Arterial thrombosis in scleroderma.

Authors:  N L Furey; F R Schmid; H C Kwaan; H H Friederici
Journal:  Br J Dermatol       Date:  1975-12       Impact factor: 9.302

7.  Lower limb amputation secondary to large vessel involvement in scleroderma.

Authors:  M I Dorevitch; L E Clemens; J B Webb
Journal:  Br J Rheumatol       Date:  1988-10

8.  Intermittent claudication: prevalence and risk factors.

Authors:  W G Hughson; J I Mann; A Garrod
Journal:  Br Med J       Date:  1978-05-27

Review 9.  Vascular disease in progressive systemic sclerosis (scleroderma).

Authors:  W L Norton; J M Nardo
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

10.  The prevalence of peripheral arterial disease in a defined population.

Authors:  M H Criqui; A Fronek; E Barrett-Connor; M R Klauber; S Gabriel; D Goodman
Journal:  Circulation       Date:  1985-03       Impact factor: 29.690

View more
  9 in total

1.  Atherosclerosis in Systemic Sclerosis: a Modern Controversy.

Authors:  Stefania L Magda; Raluca I Mincu; Carmen M Mihai; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2015-09

2.  Large vessel disease in CREST.

Authors:  J J Belch; D J Veale; T Colleridge
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

3.  Distribution of macrovascular disease in scleroderma.

Authors:  L Stafford; H Englert; J Gover; J Bertouch
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

4.  Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series.

Authors:  Julie J Paik; Ram Hirpara; Jennifer A Heller; Laura K Hummers; Fredrick M Wigley; Ami A Shah
Journal:  Semin Arthritis Rheum       Date:  2016-03-31       Impact factor: 5.532

Review 5.  Ulnar artery vasculopathy in systemic sclerosis.

Authors:  Jeong Ha Park; Yoon-Kyoung Sung; Sang-Cheol Bae; Soon-Young Song; Heong Seok Seo; Jae-Bum Jun
Journal:  Rheumatol Int       Date:  2009-04-12       Impact factor: 2.631

Review 6.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

7.  Increased prevalence of symptomatic macrovascular disease in systemic sclerosis.

Authors:  D J Veale; T A Collidge; J J Belch
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

Review 8.  Cardiovascular disease in systemic sclerosis--an emerging association?

Authors:  Gene-Siew Ngian; Joanne Sahhar; Ian P Wicks; Sharon Van Doornum
Journal:  Arthritis Res Ther       Date:  2011-08-26       Impact factor: 5.156

Review 9.  Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.

Authors:  Sergio A Jimenez
Journal:  ISRN Rheumatol       Date:  2013-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.